Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Axitinib Extends Progression-Free Survival in Kidney Cancer Trial - Internal Medicine News Digital Network |
 |
 |
|
Internal Medicine News Digital Network CHICAGO – The investigational drug axitinib prolonged median progression-free survival by 2 months, compared with sorafenib, in a randomized, phase III trial that was conducted in patients with metastatic renal cell carcinoma resistant to initial |
